Experimental ADHD Pill Targeting the Brain's Wakefulness System Shows Early Symptom Gains in a Small 50-Adult Trial
Medical Daily
An experimental ADHD pill targeting the brain's wakefulness system showed early symptom improvements in a small trial of 50 adults. The study suggests the drug may offer a new approach for managing ADHD symptoms. No significant adverse effects were reported during the trial.
All articles from 24 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.